According to Vision Research Reports, the global cell-based assay market size was estimated USD 11.87 billion in 2021 and is expected to hit around USD 28.48 billion by 2030, with a registered CAGR of 8.5% from 2022 to 2030.
According to Vision Research Reports, the global cell-based assay market size was estimated USD 11.87 billion in 2021 and is expected to hit around USD 28.48 billion by 2030, with a registered CAGR of 8.5% from 2022 to 2030.
The North America Cell-based assays market holds the dominant position in 2020 and would exhibit the highest CAGR of 6.8 % during 2021-2030.
Cell-based assays could be used in both drug-discovery screening and biomedical research applications to efficiently quantify biochemical mechanisms, cytotoxicity, off-target interactions, and biological activity. The potential advantage of these assays includes the generation of complex and biologically relevant data. Several technologies are being used in the drug development process, such as genome editing tools like CRISPR/Cas9 which drives the adoption of cell-based assays in R&D. These assays form an integral part of life science research, providing a proper understanding of several cellular phenomena in disease and health. Moreover, in a regulatory setting, these assays are also utilized for cytotoxicity testing, determining the mechanism of action, and immunogenicity studies.
Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39504
Furthermore, advancements in therapeutics platforms such as gene and cell therapies, offer a promising approach to precision medicine by introducing genes to targeted tissues or cells. Novartis AG is working towards the development of cell-based assays to offer high-quality and safe therapeutics in gene therapy. Similarly, in March 2022, Promega Corporation entered into a strategic collaboration with FUJIFILM Cellular Dynamics, Inc., that aims to advance assay development for drug discovery. Continuous advancements in this field by the companies would drive the growth of the market.
Some of the applications have been trifurcated as:
- Personalized Medicine
- Gene Therapy
- Bioprocessing
Cell-based assays are a crucial tool to characterize the functionality of biosimilars and biologics. Cultured cells provide a proper representation of the physiological conditions in which the drug function. The key application for the specific cell-based assays is mode of action (MOA) research during cytotoxicity, comparability assessment, drug development assessment, and biosimilar development. Another key factor driving the growth of the market is the significant adoption of technologies for high throughput screening methods such as drug screening, toxicity studies, invitro studies, and others. These factors are further fueling the growth of the market.
The pharmaceutical industry needs to commercialize drugs efficiently to drive innovation in the market. The industry is adopting this approach to reverse the increasing trend of costly late-stage drug failures. The rapid assay-based techniques are in huge demand to predict a higher degree of accuracy in which investigation of the new drug would be successful till commercialization. These factors are driving the growth of the market.
Impact Of Covid-19 On Cell-based Assay Market (Pre And Post Analysis)
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 as a pandemic and general wellbeing crisis of international concern. COVID-19 has impacted around 210 countries across the globe. Because of the COVID-19 pandemic, state-run administrations across the globe declared inescapable lockdowns as well as friendly distancing measures to forestall breakdown of the healthcare structure. States have additionally given constraints and preventions on undertakings and elective surgeries. These obstructions continue to influence the growth of different industries, and the enhanced response towards these regulations effect the industry. The scattering, production, and store network have been impacted, because of the execution of lockdown across the globe.
Similarly, the cell-based assay market was also impacted during the pandemic. According to the WHO, COVID-19 has been confirmed in 96,012,792 people, with 2,075,870 deaths (as of January 22, 2021). Companies have increased their R&D efforts to produce a vaccine and medications to combat the SARS-CoV-2 virus as a result of the pandemic. Vaccine-related research in pharmaceutical and biotechnological firms, research centers, and academic research institutes is regarded critical, and operations and output have been largely unaffected. Both, the availability of research funding and the demand for and manufacturing of cell-based test products are predicted to expand as a result of the increase in research activities. The industry’s participants are modifying their long- and short-term growth strategies to capitalize on opportunities in the research market by introducing innovative goods to combat the pandemic. For both, researchers and laboratories, the rise in need for COVID-19 research has provided a wide scope for cell-based 45 tests in viral infection research, vaccine development, and overall drug discovery.
A variety of COVID-19 vaccines or antiviral medications have been approved or are in development, and patients are now being treated symptomatically. The functional efficiency of the antibodies produced to neutralize the target virus is assessed for both, vaccinations and treatments. To reduce the time and boost the throughput of these experiments, cell-based assays are used. As a result, the demand for cell-based assays to provide an early indication of the symptoms in patients has increased. Thus, the final impact of COVID-19 on cell-based assay markets is positive.
Report Highlights
- By product and service type, the cell-based assay market is segmented into consumables, instruments & software, and services. Consumables dominated the market in 2021 due to largest share, which is attributed to the extensive use and repeated purchase of consumables by pharmaceutical and biopharmaceutical companies and the rise in number of preliminary studies for the development of therapeutics.
- By application type, the cell-based assay market is categorized into drug discovery, basic research, and other applications. The drug discovery application segment dominated the market in 2021 due to the largest share which can be attributed to increasing R&D investments, technological innovations in supportive processes, the introduction of new drugs, and the growing number of CROs providing drug discovery services.
- By end users, the cell-based assay market is segmented into pharmaceutical & biotechnology companies, academic & government research institutes, contract research organizations, and others. Pharmaceutical & biotechnology companies dominated the market in 2021 due to the largest share that is attributed to the increase in R&D expenditure, rise in number of drug discovery projects, and the adoption of strategic approaches such as collaborations to develop drug candidates.
- By region type, in 2021 North America accounted for the largest share of the cell-based assays market, followed by Europe. The large share of the North American regional segment can be attributed to the availability of government and private funding for life science research, the growing penetration of CROs, comprehensive drug development regulations, and the rapid adoption of advanced technologies in the region.
Key Players
- Novartis AG
- BD
- Beckman Coulter, Inc.
- Danaher
- General Electric
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Lonza
- Cell Signaling Technology, Inc.
- Perkinelmer, Inc.
- Bio-Rad Laboratories, Inc.
- Promega Corporation
Market Segmentation
- By Product
- Consumable
- Assay Kits
- Cell Lines
- Service
- Instrument
- Software
- By End-user
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Academic & Government Research Institutes
- Others
- By Application
- Drug Discovery
- ADME Studies
- Basic Research
- Predictive Toxicology
- Others
- By Regional
- North America
- Europe
- Asia-Pacific
- Latin America
- MEA
Click Here to View Full Report Table of Contents
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39504
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333